Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yi-sheng Xiao-zheng is a traditional Chinese medicine (TCM) herbal formula, formulated as granules. It has been studied in at least one randomized controlled clinical trial for the treatment of dysmenorrhea caused by pelvic endometriosis (syndrome of kidney deficiency) and for metabolic conditions such as prediabetes and mild diabetes. The precise composition of herbs, mechanism of action, and pharmacological targets are not specified in available sources. Its use aligns with TCM principles rather than Western pharmacology, and it is considered an alternative or complementary therapy[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yi-sheng Xiao-zheng.